isoxazoles has been researched along with Psychoses in 74 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (1.35) | 18.7374 |
1990's | 14 (18.92) | 18.2507 |
2000's | 21 (28.38) | 29.6817 |
2010's | 38 (51.35) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alphs, L; Amatniek, J; Canuso, CM; Deutsch, SI; Henderson, DC; Mao, L; Mikesell, C; Rodriguez, S; Sheehan, J | 1 |
Alphs, L; Bossie, CA; Fu, DJ; Sheehan, JJ; Turkoz, I | 1 |
Conway, C; Cristancho, P; Jewkes, D; Mon, T | 1 |
Chiu, NY; Hsu, WY | 1 |
Cavanna, AE; Seri, S | 1 |
Attard, A; Cornelius, V; Curtis, V; Olofinjana, O; Taylor, D | 1 |
Olofinjana, O; Taylor, D | 1 |
Hou, YC | 1 |
Creus, M; Franch, J; Gutiérrez-Zotes, A; Labad, J; Lawrie, SM; Monseny, R; Montalvo, I; Ortega, L; Reynolds, RM; Vilella, E | 1 |
Jayathilake, K; Johnson, R; Kwentus, J; Lindenmayer, JP; Meltzer, HY; Share, DB | 1 |
Hou, YC; Lai, CH | 1 |
Morrissette, DA; Stahl, SM | 1 |
Alphs, L; Canuso, CM; Fu, DJ; Lindenmayer, JP; Schooler, NR; Simonson, RB; Turkoz, I; Walling, DP | 1 |
Buckley, PF | 1 |
Gopalakrishna, G; Ithman, M; Lauriello, J | 1 |
Bäuml, J; Förstl, H; Gebhart, C; Hüther, R; Mirisch, S | 1 |
Aburashed, R; Bhatt, A; Farooq, MU; Kassab, MY; Moore, PW | 1 |
Graff-Guerrero, A; Kapur, S; Mamo, DC; Mulsant, BH; Pollock, BG; Uchida, H | 1 |
Kumar, R; Sachdev, PS | 1 |
Chen, CH; Chiu, CC; Huang, MC; Lai, YC; Pan, CH; Tsai, CJ | 1 |
Järbrink, K; Knapp, M; Locklear, J | 1 |
Kecskés, I | 1 |
Asada, T; Mizukami, K; Sato, S | 1 |
Manoj, P; Skopek, M | 1 |
Bossie, CA; Canuso, CM; Carothers, J; Kosik-Gonzalez, C; Lindenmayer, JP; Schooler, NR; Turkoz, I | 1 |
English, C; Harrington, CA | 1 |
Bossie, CA; Canuso, CM; Carothers, J; Kosik-Gonzalez, C; Lindenmayer, JP; Schooler, N; Turkoz, I; Walling, D | 1 |
López-Díaz, LM; Martínez Pérez-Balsa, A; Vadillo-Olmo, FJ | 1 |
Battisti, WP; Canuso, CM | 1 |
Choi, IG; Jon, DI; Jung, MH; Kim, JN; Lee, BC | 1 |
Boncompagni, G; Lateana, D; Mandrioli, R; Mercolini, L; Raggi, MA | 1 |
Calarge, CA; Miller, del D | 1 |
Adelsky, M; Adler, DN; Brenner, R; Madhusoodanan, S; Serper, MR | 1 |
Yang, LP | 1 |
Case, M; Hoffmann, VP; Jacobson, JG | 1 |
Grant, JS; Keltner, NL; Moore, RL | 1 |
Citrome, L; Hochfeld, M; Meng, X; Stahl, SM | 1 |
Lane, HY; Teng, PR | 1 |
Bies, RR; Mamo, DC; Mimura, M; Pollock, BG; Suzuki, T; Tsunoda, K; Uchida, H; Watanabe, K | 1 |
Coffey, MJ | 1 |
Fukatsu, N; Kanemoto, K; Kato, H; Noguchi, T; Oshima, T | 1 |
Fukui, N; Inoue, Y; Ono, S; Saito, M; Someya, T; Sugai, T; Suzuki, Y; Tsuneyama, N; Watanabe, J | 1 |
Huang, YC; Liang, CS; Yang, FW | 1 |
Franch, J; Labad, J; López, X; Monseny, R; Montalvo, I; Ortega, L; Solé, M; Vilella, E | 1 |
Chanachev, A; Conus, P; Despland, JN; Eap, CB; Ebbing, K; Herrera, F; Mall, JF; von Gunten, A | 1 |
Ancione, M; D'Arrigo, C; Madia, A; Migliardi, G; Morgante, L; Spina, E; Zoccali, R | 1 |
Aichhorn, W; Stuppaeck, C; Whitworth, AB | 1 |
Baselmans, P; Bosker, F; Bruggeman, R; Castelein, S; Knegtering, R; van den Bosch, RJ | 1 |
Chan, YH; Chong, SA; Tan, CH; Verma, SK | 1 |
Kapur, S; Labelle, A; Mamo, D; Mann, S; Mannaert, E; Reiss, J; Remington, G; Shammi, C | 1 |
Hendset, M; Nesvåg, R; Refsum, H; Tanum, L | 1 |
Oberpichler-Schwenk, H | 1 |
Melkersson, KI | 1 |
D'Hoore, P; Kushner, S; Mannaert, E; Remmerie, B; Thyssen, A | 1 |
Crocq, MA; Duval, F; Garcia Duarte, F; Guillon, MS; Mokrani, MC | 1 |
Awouters, FH; Lewi, PJ | 1 |
Cutler, AJ; Polymeropoulos, MH; Weiden, PJ; Wolfgang, CD | 1 |
Litman, RE; Potkin, SG; Torres, R; Wolfgang, CD | 1 |
Ford, B; Greene, P; Lynch, T | 1 |
Cozza, SJ; Edison, DL | 1 |
Busatto, GF; Costa, DC; Ell, PJ; Kerwin, RW; Pilowsky, LS; Verhoeff, NP | 1 |
Silva, JA; Smith, EA; Tekell, JL | 1 |
McCarthy, RH; Terkelsen, KG | 1 |
Dave, M | 1 |
Devane, CL; Risch, SC; Tyson, SC | 1 |
Remr, J | 1 |
Cesková, E; Svestka, J | 1 |
Katz, IR; Streim, J | 1 |
Doorschot, CH; Loonen, AJ; Oostelbos, MC; Sitsen, JM | 1 |
Allikmets, L; Matto, V; Pruus, K; Rudissaar, R; Skrebuhhova-Malmros, T | 1 |
Benkert, O; Hillert, A; Maier, W; Wetzel, H | 1 |
Gelders, YG; Heylen, SL; Janssen, PA; Reyntjens, AJ; Vanden Bussche, G | 1 |
Burton, P; Gelders, Y; Heylen, S; Mesotten, F; Pietquin, M; Suy, E | 1 |
11 review(s) available for isoxazoles and Psychoses
Article | Year |
---|---|
Relationship between the clinical global impression of severity for schizoaffective disorder scale and established mood scales for mania and depression.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Depression; Female; Humans; Isoxazoles; Male; Paliperidone Palmitate; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrimidines; Severity of Illness Index | 2013 |
Treating the violent patient with psychosis or impulsivity utilizing antipsychotic polypharmacy and high-dose monotherapy.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brain; Clozapine; Dibenzocycloheptenes; Drug Therapy, Combination; Heterocyclic Compounds, 4 or More Rings; Humans; Impulsive Behavior; Isoxazoles; Lurasidone Hydrochloride; Olanzapine; Paliperidone Palmitate; Piperazines; Piperidines; Polypharmacy; Psychotic Disorders; Quetiapine Fumarate; Receptors, Dopamine D2; Risperidone; Thiazoles; Violence | 2014 |
Therapeutic role of zonisamide in neuropsychiatric disorders.
Topics: Adult; Animals; Anticonvulsants; Child; Clinical Trials as Topic; Epilepsy; Humans; Isoxazoles; Psychotic Disorders; Retrospective Studies; Zonisamide | 2008 |
Akathisia and second-generation antipsychotic drugs.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Isoxazoles; Olanzapine; Piperazines; Piperidines; Prevalence; Psychomotor Agitation; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risk Factors; Risperidone; Sulpiride; Thiazoles | 2009 |
Tolerability of paliperidone: a meta-analysis of randomized, controlled trials.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Female; Humans; Isoxazoles; Male; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Randomized Controlled Trials as Topic; Schizophrenia | 2010 |
Paliperidone extended-release: a review of efficacy and tolerability in schizophrenia, schizoaffective disorder and bipolar mania.
Topics: Animals; Bipolar Disorder; Delayed-Action Preparations; Humans; Isoxazoles; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2010 |
Oral paliperidone: a review of its use in the management of schizoaffective disorder.
Topics: Administration, Oral; Humans; Isoxazoles; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Treatment Outcome | 2011 |
[Psychiatry].
Topics: Antipsychotic Agents; Depression; Electroconvulsive Therapy; Humans; Isoxazoles; Mythology; Paliperidone Palmitate; Palmitates; Psychiatry; Psychotherapy; Psychotic Disorders | 2013 |
Rapidly disintegrating risperidone in subjects with schizophrenia or schizoaffective disorder: a summary of ten phase I clinical trials assessing taste, tablet disintegration time, bioequivalence, and tolerability.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Chemistry, Pharmaceutical; Clinical Trials, Phase I as Topic; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Patient Compliance; Patient Satisfaction; Psychotic Disorders; Pyrimidines; Risperidone; Schizophrenia; Solubility; Tablets; Taste; Therapeutic Equivalency | 2007 |
Forty years of antipsychotic Drug research--from haloperidol to paliperidone--with Dr. Paul Janssen.
Topics: Antipsychotic Agents; Haloperidol; History, 20th Century; History, 21st Century; Humans; Isoxazoles; Paliperidone Palmitate; Pimozide; Psychotic Disorders; Pyrimidines; Risperidone; Structure-Activity Relationship | 2007 |
Safety profile of iloperidone: a pooled analysis of 6-week acute-phase pivotal trials.
Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Basal Ganglia Diseases; Double-Blind Method; Female; Humans; Isoxazoles; Long QT Syndrome; Male; Middle Aged; Patient Dropouts; Piperidines; Prospective Studies; Psychotic Disorders; Randomized Controlled Trials as Topic; Schizophrenia; Weight Gain | 2008 |
14 trial(s) available for isoxazoles and Psychoses
Article | Year |
---|---|
Relationship between the clinical global impression of severity for schizoaffective disorder scale and established mood scales for mania and depression.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Depression; Female; Humans; Isoxazoles; Male; Paliperidone Palmitate; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrimidines; Severity of Illness Index | 2013 |
A six month randomized controlled trial of long acting injectable risperidone 50 and 100mg in treatment resistant schizophrenia.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrimidines; Risperidone; Schizophrenia; Time Factors; Treatment Outcome; Young Adult | 2014 |
Paliperidone palmitate once-monthly reduces risk of relapse of psychotic, depressive, and manic symptoms and maintains functioning in a double-blind, randomized study of schizoaffective disorder.
Topics: Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Palmitates; Placebos; Pregnancy; Psychotic Disorders; Recurrence; Secondary Prevention; Treatment Outcome; Young Adult | 2015 |
A randomized, double-blind, placebo-controlled study of 2 dose ranges of paliperidone extended-release in the treatment of subjects with schizoaffective disorder.
Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Isoxazoles; Male; Paliperidone Palmitate; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrimidines; Treatment Outcome | 2010 |
Paliperidone extended-release in schizoaffective disorder: a randomized, controlled study comparing a flexible dose with placebo in patients treated with and without antidepressants and/or mood stabilizers.
Topics: Adult; Affect; Antidepressive Agents; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Treatment Outcome | 2010 |
Use of paliperidone in elderly patients with schizophrenia and schizoaffective disorder: a prospective open-label short-term pilot study.
Topics: Aged; Female; Humans; Isoxazoles; Male; Paliperidone Palmitate; Pilot Projects; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrimidines; Schizophrenia | 2011 |
Assessment of treatment algorithms including amantadine, metformin, and zonisamide for the prevention of weight gain with olanzapine: a randomized controlled open-label study.
Topics: Adolescent; Adult; Aged; Algorithms; Amantadine; Antipsychotic Agents; Benzodiazepines; Clinical Protocols; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Isoxazoles; Male; Metformin; Middle Aged; Olanzapine; Psychotic Disorders; Schizophrenia; Weight Gain; Zonisamide | 2012 |
Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Labeling; Female; Haloperidol; Humans; Isoxazoles; Male; Middle Aged; Piperazines; Piperidines; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome; Young Adult | 2012 |
Predicting plasma concentration of risperidone associated with dosage change: a population pharmacokinetic study.
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Dose-Response Relationship, Drug; Female; Humans; Isoxazoles; Male; Middle Aged; Nonlinear Dynamics; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Risperidone; Schizophrenia; Young Adult | 2012 |
Plasma risperidone concentrations during combined treatment with sertraline.
Topics: Adult; Antipsychotic Agents; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Risperidone; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sertraline | 2004 |
Dopamine D2 receptor blockade in vivo with the novel antipsychotics risperidone and remoxipride--an 123I-IBZM single photon emission tomography (SPET) study.
Topics: Adult; Antipsychotic Agents; Basal Ganglia; Benzamides; Cerebral Cortex; Dopamine D2 Receptor Antagonists; Female; Humans; Image Processing, Computer-Assisted; Iodine Radioisotopes; Isoxazoles; Male; Middle Aged; Neostriatum; Piperidines; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrrolidines; Remoxipride; Risperidone; Schizophrenia; Tomography, Emission-Computed, Single-Photon | 1995 |
Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses.
Topics: Adult; Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Double-Blind Method; Female; Haloperidol; Humans; Isoxazoles; Male; Piperidines; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology | 1993 |
Lack of drug interactions between mirtazapine and risperidone in psychiatric patients: a pilot study.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Depression; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Isoxazoles; Male; Mianserin; Middle Aged; Mirtazapine; Paliperidone Palmitate; Pilot Projects; Psychotic Disorders; Pyrimidines; Risperidone; Severity of Illness Index; Treatment Outcome | 1999 |
Pilot clinical investigation of risperidone in the treatment of psychotic patients.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Brief Psychiatric Rating Scale; Drug Evaluation; Female; Humans; Isoxazoles; Male; Middle Aged; Pilot Projects; Piperidines; Psychotic Disorders; Risperidone | 1990 |
50 other study(ies) available for isoxazoles and Psychoses
Article | Year |
---|---|
Safety of paliperidone extended-release in patients with schizophrenia or schizoaffective disorder and hepatic disease.
Topics: Antipsychotic Agents; Cross-Over Studies; Delayed-Action Preparations; Female; Humans; Isoxazoles; Liver Diseases; Liver Function Tests; Male; Middle Aged; Paliperidone Palmitate; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrimidines; Schizophrenia; Treatment Outcome | 2014 |
Successful use of right unilateral ECT for catatonia: a case series.
Topics: Adolescent; Adult; Aged, 80 and over; Antipsychotic Agents; Bipolar Disorder; Catatonia; Depressive Disorder, Major; Electroconvulsive Therapy; Female; GABA Modulators; Humans; Isoxazoles; Lorazepam; Lupus Erythematosus, Systemic; Male; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Schizophrenia, Catatonic; Seizures; Treatment Outcome; Young Adult | 2014 |
Early-onset tardive dyskinesia in a neuroleptic-naive patient exposed to paliperidone.
Topics: Adult; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Humans; Isoxazoles; Paliperidone Palmitate; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrimidines; Time Factors | 2013 |
Psychiatric adverse effects of zonisamide in patients with epilepsy and mental disorder comorbidities.
Topics: Adolescent; Adult; Anticonvulsants; Child; Comorbidity; Electroencephalography; Epilepsy; Female; Humans; Isoxazoles; Longitudinal Studies; Magnetic Resonance Imaging; Male; Mental Disorders; Middle Aged; Psychotic Disorders; Zonisamide | 2013 |
Paliperidone palmitate long-acting injection--prospective year-long follow-up of use in clinical practice.
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Delayed-Action Preparations; Female; Follow-Up Studies; Humans; Injections, Intramuscular; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Prospective Studies; Psychotic Disorders; Pyrimidines; Schizophrenia; Treatment Outcome; Young Adult | 2014 |
Long-acting paliperidone palmitate - interim results of an observational study of its effect on hospitalization.
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Bipolar Disorder; Cohort Studies; Delayed-Action Preparations; Drug Monitoring; Electronic Health Records; Female; Follow-Up Studies; Hospitals, Urban; Humans; Isoxazoles; Length of Stay; London; Male; Middle Aged; Paliperidone Palmitate; Palmitates; Patient Acceptance of Health Care; Patient Compliance; Psychotic Disorders; Recurrence; Schizophrenia; Young Adult | 2014 |
Improvement in psychotic symptoms and social functioning after augmentation of paliperidone with clozapine in a patient with schizoaffective disorder.
Topics: Antipsychotic Agents; Clozapine; Humans; Isoxazoles; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Social Behavior Disorders | 2014 |
Increased prolactin levels are associated with impaired processing speed in subjects with early psychosis.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Case-Control Studies; Cognition; Cognition Disorders; Female; Humans; Hyperprolactinemia; Isoxazoles; Male; Paliperidone Palmitate; Prolactin; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrimidines; Young Adult | 2014 |
Lower risk for body weight gain and better control of appetite after switching risperidone to paliperidone in a schizoaffective patient.
Topics: Adult; Antipsychotic Agents; Appetite; Body Weight; Female; Humans; Isoxazoles; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Risperidone | 2014 |
Drug development update.
Topics: Antipsychotic Agents; Drug Approval; Humans; Isoxazoles; Paliperidone Palmitate; Palmitates; Psychotic Disorders; United States; United States Food and Drug Administration | 2015 |
Does indication drive use, or does use drive indication?
Topics: Female; Humans; Isoxazoles; Male; Paliperidone Palmitate; Palmitates; Placebos; Pregnancy; Psychotic Disorders; Secondary Prevention | 2015 |
Choreatic symptoms during and after treatment with paliperidone and escitalopram.
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Chorea; Citalopram; Depressive Disorder, Major; Female; Humans; Isoxazoles; Middle Aged; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines | 2008 |
Sensitivity of older patients to antipsychotic motor side effects: a PET study examining potential mechanisms.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Basal Ganglia Diseases; Case-Control Studies; Cross-Sectional Studies; Dopamine Antagonists; Female; Humans; Isoxazoles; Male; Middle Aged; Ontario; Paliperidone Palmitate; Positron-Emission Tomography; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrimidines; Raclopride; Receptors, Dopamine D2; Risperidone; Schizophrenia; Treatment Outcome | 2009 |
Pharmacokinetics and efficacy of a direct switch from conventional depot to risperidone long-acting injection in Chinese patients with schizophrenic and schizoaffective disorders.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antipsychotic Agents; Asian People; Delayed-Action Preparations; Dyskinesia, Drug-Induced; Female; Humans; Injections, Intramuscular; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrimidines; Risperidone; Schizophrenia; Treatment Outcome; White People | 2009 |
Impact of psychotic relapse definitions in assessing drug efficacy and costs: comparison of quetiapine XR, olanzapine and paliperidone ER.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Biomarkers; Controlled Clinical Trials as Topic; Delayed-Action Preparations; Dibenzothiazepines; Female; Humans; Isoxazoles; Male; Middle Aged; Olanzapine; Paliperidone Palmitate; Placebos; Psychotic Disorders; Pyrimidines; Quetiapine Fumarate; Recurrence; Retrospective Studies; Treatment Outcome; Young Adult | 2009 |
[Successful quetiapine therapy in psychotic patients with mood elevation].
Topics: Adult; Affect; Antipsychotic Agents; Dibenzothiazepines; Drug Therapy, Combination; Euphoria; Female; Humans; Isoxazoles; Male; Medication Adherence; Middle Aged; Paliperidone Palmitate; Prolactin; Psychotic Disorders; Pyrimidines; Quetiapine Fumarate; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; Weight Gain | 2009 |
Successful treatment of extrapyramidal and psychotic symptoms with zonisamide in a patient with dementia with Lewy bodies.
Topics: Aged; Basal Ganglia Diseases; Female; Humans; Isoxazoles; Lewy Body Disease; Psychotic Disorders; Treatment Outcome; Zonisamide | 2010 |
Hyperprolactinaemia during treatment with paliperidone.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Galactorrhea; Humans; Hyperprolactinemia; Isoxazoles; Middle Aged; Paliperidone Palmitate; Patient Compliance; Piperazines; Prolactin; Psychotic Disorders; Pyrimidines; Quetiapine Fumarate; Quinolones; Recurrence; Schizophrenia, Paranoid; Young Adult | 2010 |
[Psychosis due to zonisamide: an infrequent case].
Topics: Aged; Anticonvulsants; Humans; Isoxazoles; Psychotic Disorders; Zonisamide | 2010 |
Paliperidone-induced leukopenia and neutropenia: a case report.
Topics: Adult; Antipsychotic Agents; Female; Humans; Isoxazoles; Leukopenia; Neutropenia; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines | 2011 |
Analysis of risperidone and 9-hydroxyrisperidone in human plasma, urine and saliva by MEPS-LC-UV.
Topics: Chromatography, Liquid; Humans; Isoxazoles; Linear Models; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Reproducibility of Results; Risperidone; Saliva; Sensitivity and Specificity; Solid Phase Microextraction; Spectrophotometry, Ultraviolet | 2011 |
Predictors of risperidone and 9-hydroxyrisperidone serum concentration in children and adolescents.
Topics: Adolescent; Aging; Antipsychotic Agents; Body Mass Index; Child; Child Development Disorders, Pervasive; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Drug Therapy, Combination; Female; Humans; Isoxazoles; Male; Mental Disorders; Paliperidone Palmitate; Polypharmacy; Psychotic Disorders; Pyrimidines; Risperidone; Sex Factors; Sexual Development | 2011 |
Biological perspectives: update on newer antipsychotic drugs: are they evidence based?
Topics: Antipsychotic Agents; Cyclooxygenase 2 Inhibitors; Dibenzocycloheptenes; Evidence-Based Medicine; Heterocyclic Compounds, 4 or More Rings; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Isoindoles; Isoxazoles; Lactones; Lurasidone Hydrochloride; Piperidines; Psychotic Disorders; Pyridines; Serotonin Receptor Agonists; Sulfones; Thiazoles | 2011 |
Emergence of neuroleptic malignant syndrome while switching between risperidone and paliperidone.
Topics: Adult; Antipsychotic Agents; Humans; Isoxazoles; Male; Neuroleptic Malignant Syndrome; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Risperidone | 2011 |
Catatonia and encephalopathy associated with paliperidone palmitate.
Topics: Aged; Antipsychotic Agents; Catatonia; Female; Humans; Isoxazoles; Lorazepam; Male; Neuroleptic Malignant Syndrome; Palmitates; Psychotic Disorders; Pyrimidines; Schizophrenia | 2012 |
Impact of antiepileptic drugs on genesis of psychosis.
Topics: Adolescent; Adult; Anticonvulsants; Epilepsy, Complex Partial; Female; Follow-Up Studies; Humans; International Classification of Diseases; Isoxazoles; Male; Middle Aged; Phenytoin; Psychotic Disorders; Retrospective Studies; Young Adult; Zonisamide | 2012 |
Effect of the cytochrome P450 2D6*10 allele on risperidone metabolism in Japanese psychiatric patients.
Topics: Adult; Alleles; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Female; Humans; Isoxazoles; Japan; Male; Middle Aged; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Risperidone; Schizophrenia; Young Adult | 2012 |
Rabbit syndrome following discontinuation of paliperidone in a patient with schizoaffective disorder.
Topics: Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Parkinsonian Disorders; Psychotic Disorders; Pyrimidines; Substance Withdrawal Syndrome; Syndrome | 2012 |
Changes in prolactin levels and sexual function in young psychotic patients after switching from long-acting injectable risperidone to paliperidone palmitate.
Topics: Adult; Age Factors; Antipsychotic Agents; Biomarkers; Drug Substitution; Female; Humans; Hyperprolactinemia; Injections; Isoxazoles; Male; Paliperidone Palmitate; Palmitates; Prolactin; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Recovery of Function; Risperidone; Sexual Behavior; Sexual Dysfunction, Physiological; Surveys and Questionnaires; Time Factors; Treatment Outcome; Young Adult | 2013 |
Risperidone and breast-feeding.
Topics: Adult; Antipsychotic Agents; Breast Feeding; Dose-Response Relationship, Drug; Female; Humans; Infant, Newborn; Isoxazoles; Milk, Human; Paliperidone Palmitate; Postpartum Period; Psychotic Disorders; Pyrimidines; Risperidone | 2005 |
Predominant role of the 9-hydroxy metabolite of risperidone in elevating blood prolactin levels.
Topics: Adolescent; Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hyperprolactinemia; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Prolactin; Psychotic Disorders; Pyrimidines; Risperidone | 2005 |
Plasma risperidone levels and clinical response in patients with first-episode psychosis.
Topics: Adult; Antipsychotic Agents; Asian People; Drug Monitoring; Female; Humans; Isoxazoles; Male; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Risperidone; Treatment Outcome | 2005 |
A PET study evaluating dopamine D2 receptor occupancy for long-acting injectable risperidone.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Brain; Carbon Radioisotopes; Corpus Striatum; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Injections; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Positron-Emission Tomography; Prolactin; Psychotic Disorders; Pyrimidines; Raclopride; Receptors, Dopamine D2; Risperidone; Schizophrenia | 2006 |
Serum concentrations of risperidone and 9-OH risperidone following intramuscular injection of long-acting risperidone compared with oral risperidone medication.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antipsychotic Agents; Bipolar Disorder; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Injections, Intramuscular; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Risperidone; Schizophrenia; Treatment Outcome | 2006 |
[Paliperidone].
Topics: Antipsychotic Agents; Humans; Isoxazoles; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Schizophrenia | 2006 |
Prolactin elevation of the antipsychotic risperidone is predominantly related to its 9-hydroxy metabolite.
Topics: Adult; Antipsychotic Agents; Biotransformation; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Prolactin; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrimidines; Risperidone; Schizophrenia | 2006 |
Relationship between prolactin secretion, and plasma risperidone and 9-hydroxyrisperidone concentrations in adolescents with schizophreniform disorder.
Topics: Adolescent; Adolescent Medicine; Age Factors; Antipsychotic Agents; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Isoxazoles; Male; Paliperidone Palmitate; Prolactin; Psychotic Disorders; Pyrimidines; Risperidone | 2008 |
Efficacy of iloperidone in the treatment of schizophrenia: initial phase 3 studies.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Endpoint Determination; Female; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Psychotic Disorders; Randomized Controlled Trials as Topic; Schizophrenia | 2008 |
New antipsychotic agent, risperidone, introduced.
Topics: Antipsychotic Agents; Humans; Isoxazoles; Piperidines; Psychotic Disorders; Risperidone | 1994 |
Risperidone in Parkinson's disease.
Topics: Antipsychotic Agents; Humans; Isoxazoles; Parkinson Disease; Piperidines; Psychotic Disorders; Risperidone | 1994 |
Risperidone in adolescents.
Topics: Adolescent; Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hospitalization; Humans; Isoxazoles; Male; Piperidines; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology | 1994 |
Prolonged erection associated with risperidone treatment.
Topics: Adult; Antipsychotic Agents; Humans; Isoxazoles; Male; Piperidines; Priapism; Psychotic Disorders; Risperidone | 1995 |
Risperidone augmentation of clozapine.
Topics: Adult; Antipsychotic Agents; Clozapine; Drug Therapy, Combination; Humans; Isoxazoles; Male; Piperidines; Psychotic Disorders; Risperidone; Schizophrenia, Paranoid; Schizophrenic Psychology | 1995 |
Two cases of risperidone-induced neuroleptic malignant syndrome.
Topics: Adult; Antipsychotic Agents; Female; Humans; Isoxazoles; Neuroleptic Malignant Syndrome; Piperidines; Primidone; Psychotic Disorders; Risperidone; Tremor | 1995 |
Pharmacokinetic interaction between risperidone and clozapine.
Topics: Adult; Antipsychotic Agents; Clozapine; Drug Interactions; Drug Therapy, Combination; Humans; Isoxazoles; Male; Piperidines; Psychotic Disorders; Risperidone | 1995 |
[Clinical evaluation of risperidone].
Topics: Antipsychotic Agents; Humans; Isoxazoles; Piperidines; Psychotic Disorders; Risperidone | 1993 |
New drugs may help treat psychoses.
Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Clozapine; Drug Costs; Humans; Isoxazoles; Nursing Homes; Piperidines; Psychotic Disorders; Research; United States | 1995 |
Involvement of GABAergic neurotransmission in the neurobiology of the apomorphine-induced aggressive behavior paradigm, a model of psychotic behavior in rats.
Topics: Aggression; Animals; Apomorphine; Baclofen; Behavior, Animal; Disease Models, Animal; GABA Agonists; Isoxazoles; Male; Neurotransmitter Agents; Psychotic Disorders; Rats; Rats, Wistar; Receptors, GABA-A; Receptors, GABA-B; Synaptic Transmission | 2000 |
Risperidone in the treatment of disorders with a combined psychotic and depressive syndrome--a functional approach.
Topics: Adult; Aged; Antipsychotic Agents; Depressive Disorder; Female; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Syndrome | 1992 |
Therapeutic effect and safety of increasing doses of risperidone (R 64766) in psychotic patients.
Topics: Adult; Aged; Antipsychotic Agents; Blood Pressure; Electrocardiography; Female; Hormones; Humans; Isoxazoles; Male; Middle Aged; Oxazoles; Piperidines; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone | 1989 |